Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women by unknown
Duggan et al. BMC Cancer 2012, 12:170
http://www.biomedcentral.com/1471-2407/12/170STUDY PROTOCOL Open AccessCervical cancer screening and adherence to
follow-up among Hispanic women study protocol:
a randomized controlled trial to increase the
uptake of cervical cancer screening in Hispanic
women
Catherine Duggan1*, Gloria Coronado2, Javiera Martinez1,3,4, Theresa L Byrd5, Elizabeth Carosso1, Cathy Lopez6,
Maria Benavides7 and Beti Thompson1Abstract
Background: In the US, Hispanic women have a higher incidence of, and mortality from, cervical cancer than
non-Hispanic white women. The reason for this disparity may be attributable to both low rates of screening and
poor adherence to recommended diagnostic follow-up after an abnormal Pap test. The 'Cervical Cancer
Screening and Adherence to Follow-up Among Hispanic Women' study is a collaboration between a research
institution and community partners made up of members from community based organizations, the Yakima
Valley Farm Workers Clinic and the Breast, Cervical, and Colon Health Program of the Yakima District . The study
will assess the efficacy of two culturally-appropriate, tailored educational programs designed to increase cervical
cancer screening among Hispanic women, based in the Yakima Valley, Washington, US.
Methods/design: A parallel randomized-controlled trial of 600 Hispanic women aged 21–64, who are non-compliant
with Papanicolau (Pap) test screening guidelines. Participants will be randomized using block randomization to (1) a
control arm (usual care); (2) a low-intensity information program, consisting of a Spanish-language video that educates
women on the importance of cervical cancer screening; or (3) a high-intensity program consisting of the video plus a
‘promotora’ or lay-community health educator-led, home based intervention to encourage cervical cancer screening.
Participants who attend cervical cancer screening, and receive a diagnosis of an abnormal Pap test will be assigned to
a patient navigator who will provide support and information to promote adherence to follow-up tests, and any
necessary surgery or treatment. Primary endpoint: Participants will be tracked via medical record review at
community-based clinics, to identify women who have had a Pap test within 7 months of baseline assessment.
Medical record reviewers will be blinded to randomization arm. Secondary endpoint: An evaluation of the patient
navigator program as a method to improve adherence and reduce time to follow-up among participants who
receive an abnormal Pap test result. An additional secondary endpoint is the cost-effectiveness of the two different
intensity intervention programs.* Correspondence: cduggan@fhcrc.org
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in a Hispanic population. If effective, such interventions may reduce incidence of cervical cancer.
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Cervical cancer screening detects pre-cancerous
changes in the cervix, such as cervical intraepithelial
neoplasia (CIN) or cervical dysplasia. Introduction of
the Papanicolau (Pap) test screening programs to
women in all populations reduces cervical cancer rates
by 60–90 percent within 3 years of implementation,
with the reduction of mortality and morbidity consist-
ent across populations [1,2]. In the US, the US Pre-
ventative Task Force guidelines for Pap testing are
every 3 years for routine screening by women over the
age of 21, or from three years after the age of initiation
of sexual activity, whichever is earlier [3].
Hispanic women in the US have the highest cervical
cancer incidence with an age-adjusted incidence of
12.5 cases/100,000 women for 2004–2008, compared
to an incidence of 7.0 in the non-Hispanic white
population [4]. Mortality from cervical cancer is also
higher among Hispanics compared to non-Hispanic
whites (estimates for age-adjusted U.S. mortality rates
for 2008: 2.9 per 100,000 vs. 2.1 per 100,000) [4].
The disproportionate burden of cervical cancer among
Hispanic women is thought to be attributable in part
to both low rates of screening and poor adherence to
recommended diagnostic follow-up after an abnormal
Pap test. Data from the National Health Interview
Survey show that 74.6% of Hispanic women had a
Pap test in the past three years compared to 81.4%
of non-Hispanic whites [5]. Similarly, Hispanic non-
adherence with recommended follow-up has been
reported in several regional studies to range from 20
to 90% [6,7].
Sociodemographic factors associated with non-adherence
to cervical cancer screening in this population include low
income, lack of health insurance, limited access to health-
care services, lack of clinician recommendation, length of
residency in the United States, limited English language
proficiency, acculturation, and lack of awareness of risks
associated with non-participation in cervical cancer
screening programs [8-11].
The aims of the Cervical Cancer Screening and Adher-
ence to Follow-up Among Hispanic Women study are
threefold: (1) to determine the effect of two different in-
tensity, culturally appropriate information based inter-
ventions on Pap test utilization, vs. control; (2) todetermine whether a patient navigator program can im-
prove adherence to follow-up after a diagnosis of an ab-
normal Pap test, in a sample of Hispanic women in
Yakima and Franklin counties of Washington (WA)
State, US; and (3) to assess the cost-effectiveness of each
of the intervention programs.
The study will be implemented with the aid of the two
community based partners, the Yakima Valley Farm
Workers’ Clinic (YVFWC) which operates a network of
13 federally qualified health center clinics in Eastern
Washington specializing in the delivery of primary care
services to low-income Latinos; and the Breast, Cervical,
and Colon Health Program of the Yakima District
(BCCHP), a federally funded aid program, administered
through the Washington State Department of Health,
which provides assistance and resources for women to
undergo Pap tests, and for women who receive a diagno-
sis of an abnormal Pap test.
BCCHP and YVFWC will work with the study investi-
gators to identify women who are non-compliant with
Pap testing to monitor uptake of Pap test screening
among randomized women via medical record review,
and to develop and pilot test a patient navigator program
to improve adherence and reduce time to follow-up after
an abnormal Pap test.
To aid with issues regarding cultural relevance, a com-
munity advisory board was appointed and regular meet-
ings are scheduled between the investigators and
community members.Methods/design
The ‘Cervical Cancer Screening and Adherence to Fol-
low-up Among Hispanic Women’ study is a parallel
randomized controlled trial with participants rando-
mized into a control or usual care arm; a high intensity
intervention ‘Promotora’ plus video arm; or a low-
intensity ‘video’ only arm (Figure 1). The interventions
are behavioural and information based, and are designed
to educate participants about the importance of cervical
cancer screening, and to encourage women to obtain
screening. The study will be conducted in Yakima Valley,
WA, US, and has been approved by the Institutional Re-
view Board (IRB) of the Fred Hutchinson Cancer Research
Center.
Women contacted to 
confirm eligibility & 
consented
Medical Record review at YVFWC to identify women 
who complete cervical cancer screening within 7 
months of randomization (primary endpoint)
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cervical cancer screening guidelines, aged 
21-64, identified from medical record 
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Figure 1 CONSORT diagram.
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In Washington State, much of the Hispanic population is
concentrated in Yakima County, and Hispanics are the
fastest growing population in the region, having increased
by 37% between the 2000 and 2010 census, and the per-
centage of Hispanics is 45% of the population [12].
Participants
The study aims to recruit 600 Hispanic women, who
have been seen by a community health partner clinic
(YVFWC) within the past 5 years, and who are out of
compliance with current recommendations for Pap test
screening, i.e., have not had a Pap test within the previ-
ous 3 years. Eligible women will be between 21 – 64
years of age as is consistent with guidelines, without a
prior hysterectomy. Participants may be English orSpanish speakers and are resident in the Yakima Valley
Washington, USA.
Recruitment of participants
We will use recruitment strategies that were successfully
used in our other studies involving community based
clinics [13]. Details of Hispanic females who are eligible,
who have been seen in the YVFWC clinics in the past
five years, and who are non-compliant with cervical can-
cer screening recommendations will be extracted from
computerized patient records. Eligible women will be
invited to participate in the study by the YVFWC. Inter-
ested women will be told that they will be randomized to
one of three arms in the project. The women will be
assured that refusal to participate will not have any
implications on the ability to receive care at the clinic.
Women will be asked to sign an informed consent to
participate in the project, and to sign a HIPAA
authorization for release of medical record information
for the purposes of verifying their use of cervical cancer
screening. Once consent is obtained, a study staff mem-
ber will telephone or go to the home of the participant
to complete a baseline survey. The baseline question-
naire includes items on cervical cancer screening know-
ledge and attitudes as well as intention to be screened,
acculturation, and sociodemographic variables.
Randomization
Participants will be allocated to the intervention or con-
trol arms via a computerized program. A randomized
block design assuring that randomization is balanced
after every 15 participants will be used to ensure equal
distribution across study arms. The randomization se-
quence was generated by a statistician who is not
involved with the study. Medical record reviewers will be
blinded to the randomization status of the participants.
Interventions
Following baseline assessment, the participant will be
randomized to control arm (usual care), mailed video
only, or video plus promotora outreach, as described
below.
Control arm
Participants who are allocated to the control arm (‘Usual
Care’) will not receive any motivational messages or
intervention materials from study staff. Usual care entails
any information on the importance of regular Pap tests
for cervical cancer risk reduction provided routinely by
clinic staff to all women at community clinics.
Low intensity intervention (video)
Participants will be mailed a culturally-appropriate Spanish-
language video with information and encouragement to
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resources to pay for screening, and other practical assist-
ance such as resources for transportation. This intervention
consists of a 13 minute video presentation of three dif-
ferent generational women talking in Spanish about
their experiences and concerns for cervical cancer
screening in the form of a “novela” or soap opera. The
video has English subtitles for monolingual English-
speaking participants. The video was developed as part
of the ‘Ayudando a Las Mujeres con Informacion, Guia y
Amor para su Salud’ (AMIGAS) intervention, which
consisted of a lay community health educator or pro-
motora de salud-(promotora) led in-home education
session, and a video presentation. The culturally appro-
priate, theoretically-based curriculum was developed
using a community-based participatory research ap-
proach, with the aim of increasing the uptake of cer-
vical screening for Hispanic women living along the U.S./
Mexican border [14].
High intensity intervention (video plus promotora outreach)
In this arm, women will receive a high-intensity inter-
vention that includes promotora-led in-home education
session. The educational session will include the culturally-
appropriate video (as used in the low intensity intervention)
[14], a “promise sheet” (i.e., a sheet that a woman signs to
indicate what she will do next, such as thinking about hav-
ing a Pap test, making an appointment), and a resource
sheet which lists resources such as contact information for
community resources for transportation, childcare, and
other potential barriers for successful attendance at clinic.
The promotora will have the opportunity to have a conver-
sation about cervical cancer screening and directly schedule
a Pap test for women through the clinic. For women who
are not yet ready to schedule a Pap test, the promotora will
make a telephone call to the woman two weeks later to re-
view the action steps, and assess readiness to schedule a
Pap test.
A promotora will be recruited by YVFWC from the
community and will be provided with an initial training
session lasting three days, which addresses procedures
for approaching households and delivering the interven-
tion, cervical cancer screening facts and tracking and
documentation procedures. Other studies indicate pro-
motora outreach to be a successful approach for His-
panic women [15-18].
Both the video and promotora led intervention are part
of an educational curriculum created to increase cervical
cancer screening in Hispanic women; the curriculum is
based in Social Cognitive Theory (SCT). Definitions of
social cognition vary, but central to the theory is that
people’s social behavior can be understood by examining
their beliefs about their behavior in a social context; and
that people learn not only from their own experiences,but by observing the actions of others. According to
SCT, three main factors, self-efficacy, goals and outcome
expectancies, affect the likelihood of changing a health
behavior [19,20].
Primary outcome
The primary outcome is defined as completion of a Pap
test within 7 months after baseline assessment. Partici-
pants will be tracked via medical record review at
YVFWC. Differences in Pap testing rates in intervention
and control arms will be assessed. Cost-effectiveness
analysis will examine the associated costs per woman
screened, by intervention arm.
Secondary outcomes
As part of the reason for high cervical cancer mortality
rates among Latinas is the lack of recommended follow-
up, for abnormal Pap tests, a secondary outcome is com-
pliance with such recommendations. The approach being
used is a patient navigator approach where a promotora
works closely with the participant to encourage her to at-
tain the recommended follow-up.
The first patient navigator program was introduced by
Dr. Harold Freeman, in a successful effort to increase ac-
cess to early effective medical care for breast cancer
patients at the Harlem Hospital in New York City [21].
Patient navigators aid patients in navigating barriers to
receiving care, such as competing demands of work,
family responsibilities, transportation and childcare. In
addition, Hispanic women may experience specific bar-
riers to care such as culturally specific health beliefs, im-
migration status and language barriers that would make
obtaining and completing optimal care more difficult
[22].
Following formative work interviewing Hispanic
women in the Yakima Valley who had received abnormal
Pap test results, we developed a culturally-appropriate
patient navigator program. Any participant, who receives
a diagnosis of an abnormal Pap test after their initial cer-
vical cancer screening, will be offered the services of a
patient navigator. The patient navigator will contact the
participant and guide them through potential barriers to
care, such as transportation, childcare, financial impedi-
ments and cultural or linguistic barriers. Patient navigator
contact will cease when the participant has successfully
completed follow-up diagnostic care or treatment. Patient
navigators will be selected from the different community
partner organizations to work collaboratively and ensure
sustainability of the program. Training will provide basic
knowledge on cervical cancer screening as well as commu-
nicational skills. The secondary outcome will measure the
time between diagnosis of the first abnormal Pap test, and
attendance at the clinic for follow up. Elapsed time in par-
ticipants assigned to a patient navigator will be compared
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are not part of the study.
Sample size
Power is assessed for the primary endpoint, i.e. increased
compliance with cervical cancer screening. We assume
compliance probabilities will range from 0.15 to 0.30 for
usual care, 0.30 to 0.45 for the low-intensity arm, and
0.45 to 0.60 for the high-intensity arm with at least a
0.15 difference between the low intensity and control
arms and the low and high intensity arms. Assuming a
10% loss to follow-up these power calculations are based
on a sample size of 180 in each of the three arms, as-
suming two Chi square tests will be conducted; one to
compare the low intensity arm to the control arm and
one to compare the high intensity arm to the control
arm. The overall significance level for the two tests was
targeted at 0.05 so that each test is powered with signifi-
cance level 0.025 to account for the two primary
evaluations.
Statistical analysis
The primary end-point (Pap test compliance) will be
coded as a binary variable. Evaluation of the success of
the intervention is based only on Pap test compliance at
follow-up. Chi square tests of 2 X 2 tables (compliance
Yes/No by arm Control vs. High or Low intensity inter-
vention) will be employed to assess whether intervention
arms affects the probability of compliance at follow-up.
We will randomize about 600 women (anticipated 200
per arm to each of 3 arms; control, low intensity inter-
vention, high intensity intervention) into the study,
which will allow for 10% attrition. Separate analysis will
be conducted to compare the high intensity arm to the
control arm and the low intensity arm to the control
arm, and subsequent analysis will include comparing the
low intensity arm to the high intensity arm as well as ad-
justment of the primary analysis by potential confound-
ing characteristics such as race and age, to account for
potential biases in the randomization.
Additional secondary analysis will include evaluating
the effect of contact from a patient navigator to women
who receive an abnormal Pap smear. All participants
seen at the study clinics during the course of the study
who receive an abnormal Pap smear (intervention popu-
lation) will receive a contact from the patient navigator.
These women will be compared to women who received
an abnormal Pap smear at the same clinics between 180
and 90 days prior to the start of the study when no navi-
gator calls were made (control population) as determined
by medical records. The outcome measure will be deter-
mination of follow up for an abnormal Pap smear within
90 days of initial contact by the clinic. We will compare
length of time from initial diagnosis to attendance at theclinic for recommended follow-up in the participants
who have been contacted by the patient navigator, vs. the
control population
Discussion
The ‘Cervical Cancer Screening and Adherence to Follow-
up among Hispanic Women’ study has the potential to
identify mechanisms to reduce health disparities in cer-
vical cancer incidence through increasing uptake of cancer
screening and thereby increasing early detection. The
findings of this study will help address the disparate burden
of cervical cancer among Hispanic women by implementing
an innovative program to improve rates of cervical cancer
screening, and it is the joint expectation of the research
team and the clinic system that the clinic will continue to
use the most effective and cost-effective intervention as part
of its usual service to women in need of cervical cancer
screening. Evaluation of a patient navigator program to aid
Hispanic women in overcoming obstacles to receive follow-
up care in a timely manner after a diagnosis of an abnormal
Pap test, may help to increase the proportion of women
who receive timely follow-up care in health care clinics in
rural Eastern Washington. If successful, the patient navi-
gator system may represent a method of reducing cancer
morbidity and mortality, by removing cultural and other
barriers and thus allowing women to successfully access
appropriate healthcare after a diagnosis of a cervical
abnormality.
Finally, the evaluation of cost-effectiveness of the inter-
vention arms will aid in the design of appropriate inven-
tions where financial constraints in underfunded health
care systems may be of concern.
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